{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q2'26)",
      "prediction": "BEAT",
      "answer": "pred ~$1.80 vs. cons $1.77",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total adjusted revenue (Q2'26)",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.20B vs. cons $4.19B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Japan pretax profit margin / benefit ratio",
      "prediction": "BEAT",
      "answer": "pred benefit ratio ~61.5% vs. cons/guide ~62.5% (favorable, better margin ~34-35% vs ~33%)",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS trajectory (implicit)",
      "prediction": "LOWER",
      "answer": "guide/implied ~$7.00 vs. cons $7.07 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Japan underlying earned premium (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~-1% to -2% vs. cons ~-1.5% (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Japan benefit ratio (FY2026 range)",
      "prediction": "UNCHANGED",
      "answer": "guide 60-63% vs. cons ~62% (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "U.S. benefit ratio (FY2026 range)",
      "prediction": "UNCHANGED",
      "answer": "guide 48-52% vs. cons ~49% (FY2026); Q2 likely ~48-49% normalizing up from 47.2%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Capital return / Q2 buyback pace",
      "prediction": "UNCHANGED",
      "answer": "pred ~$1.0B returned (~$0.8-1.0B buyback + $0.36 div) vs. cons ~$1.0B (Q2'26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Japan sales growth (yen) vs tough comp",
      "prediction": "LOWER",
      "answer": "pred ~+5-8% vs. cons ~+10% (Q2'26, lapping +23.2%)",
      "confidence": "LOW"
    },
    {
      "kpi": "Q3'26 assumption unlock / external reinsurance sizing",
      "prediction": "UNKNOWN",
      "answer": "guide n/a vs. cons n/a (Q3'26 net premium ratio reset); directional read only",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.0,
  "day5_path": "FADE",
  "day5_rationale": "Even with a modest EPS beat driven by favorable (and management-flagged transient) benefit-ratio tailwinds, the out-period math is negative: Japan underlying earned premium still shrinking (-1% to -2%), FY26 consensus (~$7.07) already implies a ~5.6% decline and drifts lower as benefit ratios normalize toward guide, an FX/yen translation headwind persists, and the Q3 assumption-unlock overhang plus CRE/cyber wildcards cap upside. Stock is near all-time highs (~$126, +14% YTD) and priced for clean execution, so a low-quality beat fades as estimates get trimmed.",
  "day5_confidence": "LOW"
}